Loss of hematopoietic stem cell (HSC) functions and increased risk of developing hematopoietic malignancies are severe concerning complications of anti-cancer radiotherapy and chemotherapy. We have previously shown that Thrombopoietin (TPO), a critical HSC regulator, ensures HSC chromosomal integrity and function in response to γ-irradiation by regulating their DNA damage response. TPO directly affects the double-strand break (DSB) repair machinery through increased DNA-PK phosphorylation and non-homologous end joining (NHEJ) repair efficiency and fidelity. This effect is not shared by other HSC growth factors, suggesting that TPO triggers a specific signal in HSCs facilitating DNA-PK activation upon DNA damage. The discovery of these unique signaling pathways will give means to enhance TPO desirable effects on HSCs and improving the safety of anti-cancer DNA agents. We show here that TPO specifically triggers Erk and NF-κB pathways in mouse HS and progenitors cells (HSPCs). These pathways are both required for TPO-mediated increase in DSB repair. They cooperate to induce and activate the early stress response gene, Iex-1 (ier3), upon DNA damage. Iex-1 forms a complex with pERK and the catalytic subunit of DNA-PK which is necessary and sufficient to promote TPO-increased DNA-PK activation and NHEJ DSB repair in both mouse and human HSPCs.
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Introduction
Maintenance of genomic stability is crucial for preservation of hematopoietic stem cell (HSC) self-renewal throughout life. Bone marrow (BM), and more particularly HSC, injury is one of the most serious limiting factors of therapies with DNA-damaging agents used to treat otherwise curable cancers. Indeed, exposure to ionizing radiation or chemotherapeutic drugs induces residual loss of HSC functions [1] [2] [3] and high risk to develop secondary acute myeloid leukemia or myelodysplastic syndromes (MDS). Finding ways to reduce toxicity of anticancer DNA agents through the analysis of HSC response following DNA damage would have major beneficial impact on cancer treatment-related mortality.
Double-strand breaks (DSB) are the most deleterious DNA lesions. In mammalian cells, DSBs are removed by two main repair pathways: homologous recombination and nonhomologous end joining (NHEJ). NHEJ is regarded as the predominant mechanism for DSB repair in vertebrates in response to irradiation (IR). 4 The DNA-PK complex, composed of the DNA-PK catalytic subunit and the Ku80/Ku70 heterodimer, is a major component of classical NHEJ. When this pathway is impaired the cells use an alternative and slower DNA-PKindependent NHEJ that has been shown to generate DSB-induced translocations and deletions. [4] [5] [6] Quiescent HSCs preferentially use NHEJ to repair IR-induced DSBs. 7 DSB repair through NHEJ is necessary to HSC maintenance. 8, 9 NHEJ is intrinsically error-prone and this has been shown to be responsible for the high HSC vulnerability to mutagenesis. 7 We have recently shown that the fidelity and the efficiency of HSC-intrinsic NHEJ-mediated repair can be improved by Thrombopoietin (TPO). 10 TPO is a main regulator of both megakaryocytopoiesis and HSCs. 11-13 TPO promotes NHEJ DNA repair in human and mouse
HSCs by directly stimulating DNA-PK activity. 10 This effect is critical to preserve HSC genomic stability and function in mice subjected to total body IR (TBI). However, mutations resulting in constitutive activation of MPL occur in myeloproliferative neoplasms 14 and prolonged TPO administration may cause complications such as myelofibrosis and thrombosis. 15 Finding means to enhance specifically TPO desirable effects on HSCs requires identification of TPO-induced signaling pathways involved in DNA repair.
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From Although many studies have examined signaling downstream of TPO/Mpl in megakaryocytes, little is known about the pathways evoked by this cytokine in HSCs. Our previous data showed that TPO effect on HSC DNA repair is unique as it cannot be replaced by other cytokines acting on HSCs. 10 In agreement with the fact that DNA-PK/NHEJ complexes form quickly after IR, kinetics analysis indicate that the protective effect of TPO requires the presence of TPO shortly before IR and is abolished when TPO is added to the medium after IR. This suggests that TPO triggers a specific signal in HSCs that acts as a priming event facilitating DNA-PK activation upon treatment with DNA damaging agents.
TPO has been shown to activate several signaling cascades in HSCs, including Stat5, Erk and p38. [16] [17] [18] [19] However, to our knowledge no data have been reported concerning selective TPO/Mpl signaling pathways activated in HSCs and their role under genotoxic stress.
Whether these pathways are different from those involved in TPO-mediated HSC maintenance is unknown.
We and others had shown that TPO induces a strong and sustained Erk MAPK activity in megakaryocytes that regulates their proliferation/differentiation balance. [20] [21] [22] [23] We have identified IEX-1 (IER3) as a TPO-induced Erk substrate. 24, 25 IEX-1 is a ubiquitous early response gene induced by various stress stimuli, including IR and inflammatory cytokines 26 . .
Methods

Animals and cell culture
Cells were cultured in StemSpan SFEM (StemCell Technologies) complete medium containing Flt3-Ligand (FL, 100 ng/ml), interleukin-3 (IL-3, 10 ng/ml), interleukin-6 (IL-6, 10ng/ml), stem cell factor (SCF, 100 ng/ml), and 50 ng/ml TPO (Peprotech, NJ, USA) or in the same medium without TPO. Cord blood CD34 + HSPCs were isolated and cultured as previously. 10, 25 Inhibitors were added 30 min before treatments. Cells were irradiated in vitro using a Biobeam 8000 irradiator (Gamma Service Medical GmbH, Germany).
Proximity ligation assay (PLA)
For PLA, cells were cyto-centrifugated on poly-L-lysine-coated slides and labeled with mouse anti-DNA-PKc and rabbit anti-pErk1/2 antibodies. Cells were then treated with the Duolink kit according to the manufacturer's instructions and revealed with the Duolink Far-Red detection reagent (Olink Bioscience, Sweden). Slides were mounted using Dapi Fluoromount-G (SouthernBiotech, Birmingham, AL, USA) and were visualized at room temperature using a Leica DMI 6000 (Wetzlar, Germany) microscope equipped with equipped with a 63 x 1.6 oil immersion objective and a MicroMAX 1300Y camera (Princeton Instruments Trenton, NJ, USA). Pictures were analyzed using ImageJ software (developed at the National Institute of Health, Bethesda, MD, USA)
Biochemical Assays
For western blots, 3x10 4 HSPCs were cultured for 1h at 37°C in IMDM containing 0.2% FCS and either TPO (50 ng/ml), SCF (100 ng/ml) or FL (100 ng/ml). Proteins were extracted in 
Statistical analysis
One-way ANOVA and Tukey comparison test or unpaired t-test was applied using GraphPad PrismTM version 5.0 software (GraphPad Software Inc., San Diego, CA, USA). The value of *p<0.05 was determined as significant, **p<0.01 or ***p<0.001 as highly significant.
For extended methods, see supplementary information on line.
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Results
The Erk pathway is required for TPO-mediated DSB repair in HSCs
To determine which TPO-dependent signaling pathways promoted DSB repair in HSPCs following IR, cells were cultured in media containing, IL-3, FL, SCF, IL-6 and TPO (referred to as complete medium) and kinase inhibitors of TPO/cytokine-induced signaling before IR.
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Analysis of γH2AX foci was used as a DSB marker. As previously described, cells cultured in TPO-free medium were greatly impaired in their capacity to resolve IR-induced γH2AX foci.
The MEK inhibitor, U0126, prevented TPO effect in LSK and HSC-enriched LSK-CD34 -cells
( Figure 1A-B) . By contrast, no significant effect was observed using p38 and JNK MAPK inhibitors (Supplemental Figure 1A -B). Single-cell comet assays confirmed that MEK inhibition abolished TPO-promoted DNA DSB rejoining ( Figure 1C and Supplemental 1C).
This effect is specific for TPO, as it could not be detected in Mpl -/-cells ( Figure S1C ).
Supporting a role for the Erk pathway in HSC DNA repair, Erk1 -/-LSK-CD34 -HSCs displayed increased γH2AX foci numbers 16h after TBI ( Figure 1D ). The basal levels of DNA damage in Erk1 -/-HSCs (14 + 2.5%), although higher than that of WT (7.3 + 2.5%), were not significantly different. As Mpl -/-HSPCs, Erk1 -/-cells showed decreased kinetics of γH2AX foci decay after IR in vitro which could not be improved by TPO stimulation ( Figure Supplemental 1D-E).
Exposure of LSK cells to low doses of IR in vitro induced a striking decrease in their long-term reconstituting activity which was completely prevented by a short treatment with TPO before and after IR 1,10 ( Figure 1E ). This TPO protective effect was abolished in the presence of U0126, decreasing engraftment of irradiated cells down to levels of cells treated in TPO-free media. This loss of HSC function was not resulting from increased apoptosis which remained low 24h after IR even when the inhibitor was not removed from the cultures (data not shown). In addition, U0126 did not alter the reconstitution ability of non-irradiated LSK cells ( Figure 1E ), showing that Erk pathway inhibition is not generally toxic to HSCs.
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TPO is the main activator of Erks in HSPCs
Removal of SCF from the medium had no effect on DSB repair when TPO is present ( Figure   S1C ). This confirms our previous results demonstrating that the effect of TPO is specific 10 . All the cytokines present in the complete medium are known as Erk activators in HSPCs.
However, no comparative quantitative assessment of their ability to trigger Erk activation in HSCs has been performed. To understand why only the TPO/Erk signal was able to regulate DNA damage repair, we measured Erk1/2 activation in HSPCs cultured in complete or TPOfree medium at time where TPO is activating repair, using capillary isoelectric focusing immunoassay. 37 Removal of TPO from the medium led to a striking decrease in total pErk1/2 levels ( Figure 2A and Supplemental 2A Figure 3D ). Kinetics studies showed that Iex-1 mRNA induction upon TPO and IR is rapid ( Figure 3E ), a timing which is compatible with that of an early response gene and the effect of TPO on DSB repair.
Altogether, these results indicate that Iex-1 induction in HSPCs requires TPO and IR signals, both in vitro and in vivo. However, this effect is independent of TPO-mediated Erk activation as it remained unchanged in the presence of MEK inhibitor ( Figure 3F ).
Iex-1 expression is required for TPO-induced DNA repair upon IR
As Mpl Figure 5A ). A weak activity was also detected upon IR in the absence of TPO. Correlating with the effect of TPO on Iex-1 expression, NF-κB activity was greatly enhanced when both stimuli were applied together and was abolished in Mpl +/-cells.
Supershift analysis indicated that the complexes induced by TPO and IR contained the NF-κB subunit RelA ( Figure 5B ). Iex-1 mRNA induction by TPO+IR treatment was inhibited upon incubation with NEMO peptide, a specific IKK complex inhibitor 40 ( Figure 5C ), indicating that TPO-mediated NF-κB activation is required for Iex-1 induction in HSPCs. Moreover, NEMO peptide and CAS 545380-34-5, a second NF-κB inhibitor blocking NF-κB transcription, inhibited TPO-accelerated DNA repair ( Figure 5D -E). This further supports the requirement of NF-κB-mediated increase in Iex-1 expression to ensure TPO effect on DNA repair. interaction is required for this function. To examine Iex-1-bound pErk1/2 may affect DNA-PK activation in HSPCs, we examined interactions between these proteins using PLA which allows detection in situ of physical protein-protein interactions by immunofluorescence in small cell numbers. Both pErk and pDNA-PK levels are increased upon TPO stimulation. To minimize these changes, we analyzed the interaction between the DNA-PK catalytic subunit, DNA-PKc, and pErk in cells cultured in complete medium, i.e. in the presence of TPO. We have previously shown that neither the total level of DNA-PKc nor its localization are altered by TPO and IR treatments. 10 PLA between pErk and DNA-PKc could be detected at a low level in LSK cells cultured in complete medium and was significantly increased upon IR ( Figure 6B ). Confirming the DNA-PK/Erk interaction, anti-DNA-PK antibodies could coimmunoprecipitate ERK1/2 in UT7-Mpl cells, a cell line in which TPO enhances DNA-PKdependent NHEJ repair ( Figure 6C ).
Iex
We were not able to perform PLA with the available anti-Iex-1 antibodies that do not detect Iex-1 protein in primary cells. However, PLA signal between DNA-PKc and pErk was greatly decreased in Iex-1 -/-cells as compared to WT ( Figure 6D ), indicating that IR-induced in situ pErk/DNA-PKc interaction is dependent on the presence of Iex-1.
We next assessed whether the pErk/DNA-PKc complex is required for TPO-increased DNA-PK activation upon IR. Ser2056-and Thr2609-phospho-DNA-PK foci formation is a functional marker of IR-induced DNA-PK activation and is required for NHEJ. 42, 43 As anti-pDNA-PK antibodies do not react with mouse cells, we used cord blood-derived human CD34 + HSPCs.
Both MEK and NF-κB inhibitors abolished TPO ability to increase IR-induced Ser2506-pDNA-PK foci formation in these cells ( Figure 7A -B). Similar results were found in UT7-Mpl cells (Supplemental Figure 3A) . were found to block EGF-stimulated DSB repair through both HR and NHEJ, but the mechanism by which this inhibition occurs was not described. 47 A recent report has demonstrated DNA-PKc can interact with AKT upon IR and EGF stimulation, enhancing its autophosphorylation that is needed for efficient DSB repair. 48 However, we were unable to detect AKT activation in HSPCs in response to TPO and/or IR. This is the first evidence for an interaction between DNA-PKc and activated Erks and for a direct role of this pathway in DNA-PK and NHEJ activation. Although further studies are required to determine how this occurs, our results indicate that induction of the Erk substrate IEX-1 is specifically required for this effect in both human and mouse HSPCs. We have previously shown that IEX-1 acts as a scaffold protein for activated Erks, bringing them in complex with other substrates and enabling their phosphorylation. 41 Our results with the IEX-1-ΔFTF mutant show that Iex-1 is required to bring pErks to DNA-PKc and for TPO-enhanced DNA-PK autophosphorylation.
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Thus, IEX-1 might increase DNA-PK activation by promoting its phosphorylation by Erks upon IR. However, the numerous DNA-PKc phosphorylation sites and the paucity of HSPCs preclude us to test this hypothesis. 
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